Theranostics (discontinued)

SJR Rank #32,178H-index: 199SJR: –Best quartile: N/AOpen AccessAPC: US$1,671Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Ivyspring International Publisher

Country

Australia

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • Medicine (miscellaneous)N/A
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)N/A

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Nanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryExtracellular vesicles in diseaseMicroRNA in disease regulationRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesRNA modifications and cancerCancer-related molecular mechanisms researchCancer, Hypoxia, and MetabolismPhotoacoustic and Ultrasonic Imaging

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

202220250150300450600

Detailed Information

ISSN

1838-7640

SJR Best Quartile

N/A

Region

Pacific Region

Citations per Document (2 years)

14.16

References per Document

60.10

Coverage

2011-2025

Scope

The aim of Theranostics is to provide a forum for the exchange of clinical and scientific information for the diagnostic and therapeutic molecular and nano medicine community and allied professions involved in the efforts of integrating molecular imaging and molecular therapy. Theranostics is a multidisciplinary journal that publishes innovative and original research articles reflecting fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor, nanobiosensor and bioelectronics, system biology and translational medicine, point-of-care and personalized medicine. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. In addition to primary research, Theranostics also publishes reviews, news, and commentary to understand and bridge the gap among the laboratory, clinic, and biotechnology industries. Papers in the journal are rigorously peer-reviewed.

Metrics from SCImago Journal Rank 2025. View on SCImago